Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Top-line results from the HEALOS trial are expected in the fall of 2017 Zug, Switzerland, July 5, 2017 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to...
-
TORONTO, ONTARIO--(Marketwired - July 4, 2017) - RioCan Real Estate Investment Trust ("RioCan") (TSX:REI.UN) is pleased to provide an update on its capital recycling program. On June 29,...
-
COLUMBUS, OH--(Marketwired - Jun 28, 2017) - SCI Engineered Materials, Inc. ("SCI") (OTCQB: SCIA), a global supplier and manufacturer of advanced materials for physical vapor deposition thin film...
-
CALGARY, Alberta, June 28, 2017 (GLOBE NEWSWIRE) -- Blackline Safety Corp. (TSX Venture:BLN), a leading manufacturer of connected worker safety monitoring solutions, announced record revenue in its...
-
BOSTON, June 28, 2017 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company focused on new immunotherapies, today announced the initiation of enrollment in the...
-
LOS ANGELES, CA--(Marketwired - Jun 28, 2017) - NEVERDIE (https://neverdie.com/), the most established name in real currency MMORPG's and Virtual Worlds, today announced a Billion Dollar NEVERDIE...
-
NEW YORK, June 27, 2017 (GLOBE NEWSWIRE) -- Morgan James’s new release, 7 Mindsets of Success: What You Really Need to Do to Achieve Rapid, Top-Level Success written by Sten Morgan, outlines seven...
-
Stowe, Vt., June 26, 2017 (GLOBE NEWSWIRE) -- Inntopia is pleased to announce that Trish Buyer is transitioning to a new, full-time role as Senior Vice President Finance and Systems Operations. In...
-
ARLINGTON, Va., June 26, 2017 (GLOBE NEWSWIRE) -- Self-awareness, an understanding of peers’ practices and adaptability are central to the evolutionary success experienced by the world’s leading...
-
Voyager Therapeutics Announces Clinical Trial Update with VY-AADC01 for Advanced Parkinson’s Disease
CAMBRIDGE, Mass., June 26, 2017 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe neurological...